Profil
Yves L'Epine is currently the Chairman at Abarem SASU, Abalux SAS, and Mci Falco.
Previously, he served as the Chief Executive Officer at Guerbet SA from 2019 to 2020, Chairman & Chief Executive Officer at Takeda France SAS from 1999 to 2010, and Vice President-Established Products Division at Abbott Laboratories from 2010 to 2011.
Dr. L'Epine holds an MBA from INSEAD and a doctorate from Université de Paris 5 René Descartes.
Aktive Positionen von Yves L'Epine
| Unternehmen | Position | Beginn |
|---|---|---|
Abarem SASU | Vorsitzender | - |
Abalux SAS | Vorsitzender | - |
Mci Falco | Vorsitzender | - |
Ehemalige bekannte Positionen von Yves L'Epine
| Unternehmen | Position | Ende |
|---|---|---|
| GUERBET | Vorstandsvorsitzender | 01.01.2020 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01.01.2011 |
Takeda France SAS
Takeda France SAS Pharmaceuticals: MajorHealth Technology Engages in research and development of biopharmaceutical products | Vorstandsvorsitzender | 01.01.2010 |
Ausbildung von Yves L'Epine
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Abbott Laboratories
Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Guerbet SA
Guerbet SA Medical SpecialtiesHealth Technology Engages in research, development and production of X-Rays and its by products | Health Technology |
INSEAD
INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université de Paris 5 René Descartes
Université de Paris 5 René Descartes Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Takeda France SAS
Takeda France SAS Pharmaceuticals: MajorHealth Technology Engages in research and development of biopharmaceutical products | Health Technology |
Abarem SASU | |
Abalux SAS | |
Mci Falco |
















